Skip Navigation

Profile

Stefan Charles Grant, M.D., J.D.Wake Forest Baptist Health

Doctor Rating

4.6 out of 5

81 Ratings
10 Comments
 

Stefan Charles Grant, M.D., J.D.

Associate Professor,

Clinical Interests

Thoracic Cancer

Contact Information

Returning Patient Appointments: 336-713-5440
Department: 336-713-5172

Insurance Accepted »

Education & Training

  • M.B.,B.Ch., University of the Witwatersrand-South Africa, 1981
  • J.D., Fordham University, 1998
  • Residency, Internal Medicine, ICR Royal Marsden Cancer Hosp, 1983
  • Residency, Internal Medicine, Albert Einstein Med Ctr, 1988
  • Fellowship, Hematology And Oncology, Memorial Sloan Kettering Cance, 1992

Board Certifications

  • American Board of Internal Medicine, Hematology
  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Medical Oncology

NPI Number

  • 1407979032
Stefan Charles Grant, M.D., J.D.

Doctor Rating

4.6 out of 5

81 Ratings
10 Comments
 

Stefan Charles Grant, M.D., J.D.

Associate Professor, Hematology & Oncology

Research Interests

Lung Neoplasms; Genotype; Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Non-Small-Cell Lung
More »

Contact Information

Academic: 336-716-4464 | Department: 336-713-5172

Recent Publications

Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system?. Yang M, Forbes ME, Bitting RL, O'Neill SS, Chou PC, Topaloglu U, Miller LD, Hawkins GA, Grant SC, DeYoung BR, Petty WJ, Chen K, Pasche BC, Zhang W.. Ann Oncol. 2018;29(2):311-323.

Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages. Yang M, Topaloglu U, Petty WJ, Pagni M, Foley KL, Grant SC, Robinson M, Bitting RL, Thomas A, Alistar AT, Desnoyers RJ, Goodman M, Albright C, Porosnicu M, Vatca M, Qasem SA, DeYoung B, Kytola V, Nykter M, Chen K, Levine EA, Staren ED,.. J Hematol Oncol. 2017;10(1):100.

Mutational landscapes of smoking-related cancers in Caucasians and African Americans: precision oncology perspectives at Wake Forest Baptist Comprehensive Cancer Center. Kytola V, Topaloglu U, Miller LD, Bitting RL, Goodman MM, D Agostino RB Jr, Desnoyers RJ, Albright C, Yacoub G, Qasem SA, DeYoung B, Thorsson V, Shmulevich I, Yang M, Shcherban A, Pagni M, Liu L, Nykter M, Chen K, Hawkins GA, Grant SC,.. Theranostics. 2017;7(11):2914-2923.

Prediction of response to first line treatment for metastatic non-small cell lung cancer [abstract]. Badawy A, Khedr G, Arafat W, Bae S, Omar A, Grant S.. J Thorac Oncol. 2017;12(1 Suppl):S908.

Hyponatremia and hypoalbuminemia as predictive factors for response to first line treatment for metastatic non-small cell lung cancer [abstract]. Badawy AA, Khedr G, Omar A, Bae S, Arafat W, Grant S.. Ann Oncol. 2016;27(Suppl 6):118P.

Identification of independent negative prognostic factors in stage IV non-small cell lung cancer [abstract]. Badawy AA, Bae S, Grant SC.. J Clin Oncol. 2015;33(15 Suppl):e19133.

An evaluation of systemic therapy beyond second-line therapy in patients with stage IV non-small cell lung cancer [abstract]. Badawy AA, Bae S, Grant SC.. J Clin Oncol. 2015;33(15 Suppl):e19129.

Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC). Allendorf DJ, Bordoni RE, Grant SC, Saleh MN, Reddy VB, Jerome ML, Dixon PM, Miley DK, Singh KP, Robert F.. Cancer Chemother Pharmacol. 2015;76(5):949-955.

Treatment beyond second line chemotherapy outside of a clinical trial is appropriate for selected NSCLC patients [abstract]. Badawy AA, Bae S, Grant SC.. J Thorac Oncol. 2015;10(9 Suppl 2):S654.

An evaluation of chemotherapy regimens in an unselected population of NSCLC patients [abstract]. Badawy AA, Bae S, Grant SC.. J Thorac Oncol. 2015;10(9 Suppl 2):S317.

Checkpoint kinase (CHK) 1/2 inhibitor LY2606368 in a phase I dose-expansion study in patients with squamous cell carcinoma of the head and neck [abstract]. Bendell J, Grant S, Janku F, Infante J, William WN, Bauer TM, Piha-Paul S, Martinez R, Wijayawardana S, Lin J, Golden L, Lin AB, Hong D.. Cancer Res. 2015;75(15 Suppl):CT240.

Making the diagnosis of cardiac tamponade in lung cancer patients [abstract]. Ghatalia P, Wang C, Grant SC.. J Thorac Oncol. 2015;10(9 Suppl 2):S537.

Robotic thoracic surgery for elderly patients with non-small cell lung cancer [abstract]. Hughes RT, Dipasquale VM, Grant SC, Lally BE, Petty WJ, Proto A, Wudel LJ.. J Thorac Oncol. 2015;10(9 Suppl 2):S561.

Nodal staging via robotic-assisted thoracic surgery for clinical stage I non-small cell lung cancer [abstract]. Dipasquale VM, Hughes RT, Grant S, Lally BE, Petty WJ, Proto A, Wudel LJ.. J Thorac Oncol. 2015;10(9 Suppl 2):S333.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Hematology & Oncology

Clinical Interests

Thoracic Cancer
Stefan Charles Grant, M.D., J.D.

Stefan Charles Grant, M.D., J.D.

Associate Professor, Hematology & Oncology

Doctor Rating

4.6 out of 5

Stefan Charles Grant, M.D., J.D.81 Ratings
10 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.7
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.8
Time CP spent with patient
4.6
Wait time at clinic
3.9



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

2/11/2018

very helpful

1/20/2018

Dr. Grant has been the best.

1/15/2018

good

10/31/2017

good

9/22/2017

Good.

7/24/2017

Jesus Christ and *Doctor Grant have gave an new life.

6/29/2017

Good.

5/23/2017

Good.

5/1/2017

I have always been a very independent person, but a time came when I had a depend on others. It Jesus Christ. And *Doctor Grant. #9. WOW.

4/24/2017

When *Dr. Matsingo left I got *Dr. Grant and we established a good rapport. He is soft spoken and very caring. He approaches you with true kindness. He is indeed an asset to Baptist Hospital.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.